Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NCSM
4876
DELISTED
NCS Multistage Holdings
NCSM
| $2.42K | ﹤0.01% |
+82
| New | +$2.51K |
2025 Q2
0 quarters
|
|
|
OKUR
4877
OnKure Therapeutics
OKUR
$104M
| $2.38K | ﹤0.01% |
996
-5,769
| -85% | -$15.1K |
2022 Q1
13 quarters
|
|
4878
Orchestra BioMed
OBIO
$358M
| $2.34K | ﹤0.01% |
874
-24,735
| -97% | -$72.2K |
2023 Q1
9 quarters
|
|
4879
Polestar Automotive Holding ADS Class C-1
PSNYW
$699M
| $2.25K | ﹤0.01% |
521
| – | – |
2022 Q2
12 quarters
|
|
|
EHLD
4880
Euroholdings Ltd
EHLD
$33.3M
| $2.24K | ﹤0.01% |
290
| – | – |
2025 Q1
1 quarter
|
|
4881
LanzaTech
LNZA
$79.1M
| $2.23K | ﹤0.01% |
82
-1,220
| -94% | -$29.9K |
2023 Q2
8 quarters
|
|
4882
ESS Tech
GWH
$6.31M
| $2.22K | ﹤0.01% |
1,670
| – | – |
2022 Q1
13 quarters
|
|
|
QMMM
4883
DELISTED
QMMM Holdings
QMMM
| $2.22K | ﹤0.01% |
1,586
| – | – |
2024 Q3
3 quarters
|
|
4884
Brilliant Earth
BRLT
$23.5M
| $2.08K | ﹤0.01% |
1,515
| – | – |
2021 Q4
14 quarters
|
|
|
IRS
4885
IRSA Inversiones y Representaciones
IRS
$1.13B
| $2.06K | ﹤0.01% |
148
| – | – |
2024 Q1
5 quarters
|
|
|
LIMN
4886
Liminatus Pharma
LIMN
$5.24M
| $2.05K | ﹤0.01% |
+4
| New | +$2.25K |
2025 Q2
0 quarters
|
|
4887
Innovator US Equity Ultra Buffer ETF February
UFEB
$176M
| $2.02K | ﹤0.01% |
+59
| New | +$1.94K |
2025 Q2
0 quarters
|
|
|
LJUL
4888
Innovator Premium Income 15 Buffer ETF - July
LJUL
$8.97M
| $2K | ﹤0.01% |
84
| – | – |
2025 Q1
1 quarter
|
|
4889
Alpha Pro Tech
APT
$51.9M
| $2K | ﹤0.01% |
426
| – | – |
2024 Q3
3 quarters
|
|
|
RDNW
4890
RideNow Group
RDNW
$210M
| $1.91K | ﹤0.01% |
828
-16,488
| -95% | -$37K |
2024 Q2
4 quarters
|
|
|
AKYA
4891
DELISTED
Akoya BioSciences
AKYA
| $1.84K | ﹤0.01% |
1,412
-28,826
| -95% | -$34.7K |
2022 Q1
13 quarters
|
|
|
IRD
4892
Opus Genetics
IRD
$381M
| $1.79K | ﹤0.01% |
1,900
| – | – |
2025 Q1
1 quarter
|
|
4893
Gilat Satellite Networks
GILT
$773M
| $1.75K | ﹤0.01% |
247
| – | – |
2023 Q3
7 quarters
|
|
4894
Deutsche Bank
DB
$65.7B
| $1.7K | ﹤0.01% |
+58
| New | +$1.53K |
2025 Q2
0 quarters
|
|
4895
Passage Bio
PASG
$13.3M
| $1.69K | ﹤0.01% |
211
| – | – |
2022 Q1
13 quarters
|
|
4896
Shattuck Labs
STTK
$675M
| $1.67K | ﹤0.01% |
2,114
-48,771
| -96% | -$47.3K |
2024 Q1
5 quarters
|
|
4897
Precision BioSciences
DTIL
$174M
| $1.61K | ﹤0.01% |
384
| – | – |
2019 Q2
24 quarters
|
|
4898
Q32 Bio
QTTB
$245M
| $1.57K | ﹤0.01% |
1,053
-8,117
| -89% | -$13.8K |
2018 Q2
28 quarters
|
|
4899
Altisource Portfolio Solutions
ASPS
$72.7M
| $1.34K | ﹤0.01% |
+157
| New | +$1.15K |
2025 Q2
0 quarters
|
|
|
SZZLU
4900
Sizzle Acquisition Corp II Unit
SZZLU
| $1.29K | ﹤0.01% |
+126
| New | +$1.27K |
2025 Q2
0 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.